Cargando…
CORRIGENDUM FOR “Assessment ofβ Cell Mass and Function by AIRmax and Intravenous Glucose in High-Risk Subjects for Type 1 Diabetes”
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Endocrine Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285866/ https://www.ncbi.nlm.nih.gov/pubmed/29408995 http://dx.doi.org/10.1210/jc.2018-00226 |
Ejemplares similares
-
CORRIGENDUM FOR “Eating Patterns and Health Outcomes in Patients With Type 2 Diabetes”
Publicado: (2018) -
Effects of intravenous glucose and lipids on innate immune cell activation in healthy, obese, and type 2 diabetic subjects
por: Horvath, Peter, et al.
Publicado: (2015) -
Corrigendum to “Effect of Intervention in Subjects with High Risk of Diabetes Mellitus in Pakistan”
por: Hydrie, Muhammad Zafar Iqbal, et al.
Publicado: (2015) -
[Corrigendum] Changes of type II collagenase biomarkers on IL‑1β‑induced rat articular chondrocytes
por: Ma, Xiangying, et al.
Publicado: (2023) -
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study
Publicado: (2014)